Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Nikolaos Papanas and Manfredi Rizzo.
Nikolaos Papanas
Connection Strength
1.484
Manfredi Rizzo
  1. Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights. J Cardiovasc Pharmacol Ther. 2020 11; 25(6):494-496.
    View in: PubMed
    Score: 0.223
  2. Advances in pharmacological treatment of type 1 diabetes during pregnancy. Expert Opin Pharmacother. 2019 06; 20(8):983-989.
    View in: PubMed
    Score: 0.204
  3. Pharmacotherapy for gestational diabetes mellitus: still insulin, or what about sulfonylureas? Ann Transl Med. 2018 Nov; 6(Suppl 1):S79.
    View in: PubMed
    Score: 0.198
  4. Pharmacotherapy for gestational diabetes. Expert Opin Pharmacother. 2018 09; 19(13):1407-1414.
    View in: PubMed
    Score: 0.196
  5. New antihyperglycaemic agents and cardiovascular disease: let's be optimistic. Curr Opin Cardiol. 2018 07; 33(4):444-454.
    View in: PubMed
    Score: 0.194
  6. Metabolic disorders during pregnancy and postpartum cardiometabolic risk. Endocr Connect. 2018 May; 7(5):E1-E4.
    View in: PubMed
    Score: 0.191
  7. GLP-1 receptor agonists, carotid atherosclerosis and retinopathy. Expert Opin Pharmacother. 2017 08; 18(12):1163-1165.
    View in: PubMed
    Score: 0.180
  8. Future perspectives of the pharmacological management of diabetic dyslipidemia. Expert Rev Clin Pharmacol. 2019 Feb; 12(2):129-143.
    View in: PubMed
    Score: 0.050
  9. Metabolic Syndrome and Vitamin D Levels in Patients with Obstructive Sleep Apnea Syndrome. Metab Syndr Relat Disord. 2018 05; 16(4):190-196.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.